Biopharma Patrys Limited (ASX:PAB) has hired Suzy Jones as non-executive director, to help with its ongoing transition into a clinical development company. Jones is also founder and managing partner of Californian life sciences business licensing firm DNA Ink. She has had a 22-year career, holding prior positions including Head of Business Development at Genentech.
Any opinions on the appointment?
http://www.lifescientist.com.au/article/412799/movers_shakers/
Biopharma Patrys Limited (ASX:PAB) has hired Suzy Jones as...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $5.645K | 806.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 182559 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 1986479 | 10 |
View Market Depth
| Last trade - 11.13am 26/06/2024 (20 minute delay) ? |
| PAB (ASX) Chart |